Skip to main content
OpenTrials
Completed

NCT Number: NCT02857400

Evaluation of an Organized Consultation "Return Home" of Patients With a Cancer (CREDO)

Prospective, open label, randomized and multicentric study evaluating the efficacy of an organized consultation "return home" compared to a current standard of care in patient hospitalized due to metastatic solid tumor cancer.

Subject will be randomized (1:1) as described below :

• Arm A (standard) : current standard of care ; connection documentation faxed to GP ( General practitioner) on the day of patient's discharge Arm B (experimental) : CREDO standard of care, organized consultation "return home" between patient, GP DESC (diploma of complementary specialized study) and patient's referent GP

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Metastatic Cancer Neoplasm Metastasis Neoplasms Neoplastic Processes Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Centre Hospitalier Auch, Auch, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age > or = 18 years old
  • Subject hospitalized in an oncology dedicated center for administration of the first chemotherapy cycle.
  • Subject with metastatic solid tumor whatever the organ
  • subject planned to be discharged home after chemotherapy administration
  • Affiliated to the French social security system.
  • Subjects must provide written informed consent prior to any study-specific procedure or assessment

Exclusion criteria

  • Subject included in another trial evaluating the pathways care
  • Pregnant or breastfeedings women
  • Subject law protected

Treatment and study plan

Current standard of care

Other

connection documentation faxed to GP (General practitioner) on the day of patient's discharge

CREDO standard of care

Other

organized consultation "return home" between patient, GP DESC (diploma of complementary specialized study) and patient's referent GP

Primary outcomes

  1. Evaluation of an organized consultation "return home" of patients with a metastatic cancer

    Time frame: up to 12 months

    Evaluation of number of non planned consultation and hospitalization compared to current standard of care

Secondary outcomes

  1. Comparison of the 2 standard of care (current and CREDO) regarding subject' satisfaction

    Time frame: up to 12 months

    phone call , specific question

  2. Comparison of the 2 standard of care (current and CREDO) regarding subject's quality of life

    Time frame: up to 12 months

    quality of life questionnaire

  3. Identification of the conformity of the standard of care regarding the place of care

    Time frame: up to 12 months

    Comparison with the initial predefined place of standard of care

  4. To quantify the caregiver burden in the 2 standard of care (current and CREDO)

    Time frame: up to 12 months

    Zarit Burden Interview

  5. To assess the medical and economic consequences of the 2 standard of care (current and CREDO)

    Time frame: up to 12 months

    A cost effectiveness analysis will be performed

Sponsors and collaborators

Lead sponsor

Institut Claudius Regaud

Other

Registry information

Acronym: CREDO

Important dates

Study start
2017
Primary completion
2022
Study completion
2022
First posted
Aug 5, 2016
Registry last updated
Apr 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.